Table S XI.
Tenders identified for the Imatinib drug between years 2017 and 2021.
| ORGANISM | BATCH DATA | AWARD DATA | |||||
|---|---|---|---|---|---|---|---|
| Region | Convening body | Product requested by the agency | Volume for tender’s duration (mg) | Maximum bid price (€/mg) | Awardee | Award price (€/mg) | Award date |
| Madrid | Hospital Universitario de Getafe | IMATINIB 400 MG. COMP. | 4,020,000 | 0.0067 | TEVA PHARMA | 0.0014 | 27/01/2020 |
| Andalucía | Plataforma de Logística Sanitaria de Jaén | IMATINIB 400MG, COMPRIMIDOS | 1,400,000 | 0.0170 | TEVA PHARMA | 0.0013 | 12/03/2020 |
| Asturias | Servicio de Salud del Principado de Asturias (Sespa) | IMATINIB 100 MG | 1,438,000 | 0.0022 | CIPLA EUROPE | 0.0012 | 15/05/2020 |
| Asturias | Servicio de Salud del Principado de Asturias (Sespa) | IMATINIB 400 MG | 12,252,000 | 0.0022 | CIPLA EUROPE | 0.0012 | 15/05/2020 |
| Cataluña | Institut Català d’Oncologia (ICO) | IMATINIB 100 mg comprimits/caps | 4,140,000 | 0.0024 | CIPLA EUROPE | 0.0011 | 21/05/2020 |
| Cataluña | Institut Català d’Oncologia (ICO) | IMATINIB 400 mg comprimits/caps | 43,272,000 | 0.0015 | CIPLA EUROPE | 0.0011 | 21/05/2020 |
| Asturias | Servicio de Salud del Principado de Asturias (Sespa) | GLIVEC 100 mg/60 comprimidos | 432,000 | 0.0114 | NOVARTIS FARMACEUTICA | 0.0114 | 07/07/2020 |
| Asturias | Servicio de Salud del Principado de Asturias (Sespa) | GLIVEC 400 mg/30 comprimidos | 4,176,000 | 0.0114 | NOVARTIS FARMACEUTICA | 0.0114 | 07/07/2020 |
| Cataluña | Consorci Hospital Clínic de Barcelona (HCB) | IMATINIB MESILATO 100 MG COMP o CAPS (generico) | 3,438,600 | 0.0012 | ACCORD HEALTHCARE | 0.0011 | 16/12/2020 |
| Cataluña | Consorci Hospital Clínic de Barcelona (HCB) | IMATINIB 100 MG COMP (original) | 357,100 | 0.0114 | NOVARTIS FARMACEUTICA | 0.0114 | 16/12/2020 |
| Cataluña | Consorci Hospital Clínic de Barcelona (HCB) | IMATINIB 400 MG COMP/CAPSULAS ORIGINAL | 2,028,000 | 0.0114 | NOVARTIS FARMACEUTICA | 0.0114 | 16/12/2020 |
| País Vasco | Osakidetza-S.v.s. | IMATINIB (DOE) | 3,150,000 | 0.0114 | NOVARTIS FARMACEUTICA | 0.0058 | 16/03/2021 |
| País Vasco | Osakidetza-S.v.s. | IMATINIB (DOE) | 12,600,000 | 0.0114 | NOVARTIS FARMACEUTICA | 0.0058 | 16/03/2021 |
| País Vasco | Osakidetza-S.v.s. | IMATINIB (DOE) | 6,000,000 | 0.0040 | ACCORD HEALTHCARE | 0.0009 | 16/03/2021 |
| País Vasco | Osakidetza-S.v.s. | IMATINIB (DOE) | 24,000,000 | 0.0040 | ACCORD HEALTHCARE | 0.0012 | 16/03/2021 |
| Andalucía | Plataforma de Logística Sanitaria de Sevilla | IMATINIB 400MG - ORAL | 12,000,000 | 0.0012 | ACCORD HEALTHCARE | 0.0012 | 13/04/2021 |
| Andalucía | Plataforma de Logística Sanitaria de Sevilla | IMATINIB 100MG - ORAL | 2,500,000 | 0.0019 | ACCORD HEALTHCARE | 0.0010 | 13/04/2021 |